Arpita Ray Sinha
About Arpita Ray Sinha
Arpita Ray Sinha is a Senior Principal Scientist at BenevolentAI in London, United Kingdom, with extensive experience in drug discovery and target validation projects.
Title
Arpita Ray Sinha holds the position of Senior Principal Scientist. She is currently employed at BenevolentAI in London, United Kingdom.
Company
Since February 2017, Arpita Ray Sinha has been working at BenevolentAI, a company based in London. BenevolentAI focuses on using artificial intelligence in drug discovery and molecular biology research.
Previous Roles
From 2015 to 2017, Arpita worked as a Research Scientist at Kesios Therapeutics, specifically in the Imperial College Incubator, South Kensington, London. Prior to that, she was involved in a Drug Discovery and Target Validation Project at The Institute of Cancer Research in Sutton, United Kingdom from 2013 to 2015. She also served as a Postdoctoral Research Associate at the University of Liverpool's School of Cancer Studies from 2007 to 2010.
Education and Expertise
Arpita Ray Sinha holds a Master’s Degree in Physiology from the University of Liverpool. She furthered her academic qualifications by obtaining a Doctor of Philosophy (Ph.D.) in Cell Biology and Biochemistry from the University of Manchester. Her academic background has provided her with extensive experience in drug discovery and target validation projects.
Background in Cancer Studies
Arpita has a robust background in cancer studies, developed during her three-year tenure as a Postdoctoral Research Associate at the University of Liverpool's School of Cancer Studies. Her work during this period contributed significantly to her expertise in drug discovery and cancer research.